Predictive and Prognostic Value of ABO Blood Group in Patients Using Immune Checkpoint Inhibitor for Advanced Renal Cell CarcinomaYakup ERGÜNa, Gökhan UÇARb, Selin AKTÜRK ESENb, Murat BARDAKÇIb, Ziya KALKANc, Zuhat URAKÇIc, Erdoğan ŞEYRANd, Mutlu DOĞANd, Gökşen İnanç İMAMOĞLUe, Ozan YAZICIf, Seda KAHRAMANb, Yusuf AÇIKGÖZb, Doğan UNCUbaClinic of Medical Oncology, Batman Training and Research Hospital, Batman, Türkiye
bDepartment of Medical Oncology, University of Health Sciences Ankara City Hospital, Ankara, Türkiye
cDepartment of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakır, Türkiye
dClinic of Medical Oncology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Türkiye
eClinic of Medical Oncology, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Türkiye
fDepartment of Medical Oncology, Gazi University Faculty of Medicine, Ankara, TürkiyeDOI: 10.37047/jos.2022-90679 Sayfalar: 100 - 106 1117 Viewed.
JOURNAL of
EN